RESUMO
To compare the efficacy of mometasone furoate and tacrolimus in the treatment of atopic dermatitis. Sixty patients of atopic dermatitis were treated with mometasone furoate 0.1% [n=30] and tacrolimus 0.03% [n=30]. Both treatments were applied twice daily for 12 weeks. Patients were followed up monthly. The disease severity assessed by SCORAD index. A 4-point scale was used to measure the level of response to treatment. Before treatment the respective mean SCORAD was 30.57 +/- 13.62 and 30.90 +/- 17.17 in group A and B and at the end of treatment decreased to 11.87 +/- 12.04 and 11.20 +/- 13.85, respectively [p>0.05]. Percent reduction of severity from baseline to final follow-up was 69.20 +/- 23.41 in group A and 74.77 +/- 23.30 in group B [p=0.360]. At final follow-up 56.7% of group A and 63.3% of group B achieved excellent response, 13.3% of group A and 16.7% of group B achieved good response. We conclude that both treatments, mometasone furoate and tacrolimus, are effective in the treatment of atopic dermatitis